These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29478760)

  • 1. The attributable cost of catheter-associated urinary tract infections in the United States: A systematic review.
    Hollenbeak CS; Schilling AL
    Am J Infect Control; 2018 Jul; 46(7):751-757. PubMed ID: 29478760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicare reimbursement attributable to catheter-associated urinary tract infection in the inpatient setting: a retrospective cohort analysis.
    Yi SH; Baggs J; Gould CV; Scott RD; Jernigan JA
    Med Care; 2014 Jun; 52(6):469-78. PubMed ID: 24699236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial impact of Medicare's nonpayment policy on catheter-associated urinary tract infections by hospital characteristics.
    Schuller K; Probst J; Hardin J; Bennett K; Martin A
    Health Policy; 2014 Apr; 115(2-3):165-71. PubMed ID: 24361201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nonpayment for hospital-acquired, catheter-associated urinary tract infection: a statewide analysis.
    Meddings JA; Reichert H; Rogers MA; Saint S; Stephansky J; McMahon LF
    Ann Intern Med; 2012 Sep; 157(5):305-12. PubMed ID: 22944872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catheter-associated urinary tract infections (CAUTIs) and non-CAUTI hospital-onset urinary tract infections: Relative burden, cost, outcomes and related hospital-onset bacteremia and fungemia infections.
    Kelly T; Ai C; Jung M; Yu K
    Infect Control Hosp Epidemiol; 2024 Jul; 45(7):864-871. PubMed ID: 38374686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care.
    Tambyah PA; Knasinski V; Maki DG
    Infect Control Hosp Epidemiol; 2002 Jan; 23(1):27-31. PubMed ID: 11868889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs.
    Umscheid CA; Mitchell MD; Doshi JA; Agarwal R; Williams K; Brennan PJ
    Infect Control Hosp Epidemiol; 2011 Feb; 32(2):101-14. PubMed ID: 21460463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of hospital-acquired catheter-associated urinary tract infections from Medicare claims: sensitivity and positive predictive value.
    Zhan C; Elixhauser A; Richards CL; Wang Y; Baine WB; Pineau M; Verzier N; Kliman R; Hunt D
    Med Care; 2009 Mar; 47(3):364-9. PubMed ID: 19194330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating hospital costs of catheter-associated urinary tract infection.
    Kennedy EH; Greene MT; Saint S
    J Hosp Med; 2013 Sep; 8(9):519-22. PubMed ID: 24038833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Hospital-Acquired Conditions (HAC) reduction program: using cranberry treatment to reduce catheter-associated urinary tract infections and avoid Medicare payment reduction penalties.
    Saitone TL; Sexton RJ; Sexton Ward A
    J Med Econ; 2018 Jan; 21(1):97-106. PubMed ID: 29064320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary tract infections.
    Chenoweth CE; Saint S
    Infect Dis Clin North Am; 2011 Mar; 25(1):103-15. PubMed ID: 21315996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and health-economic burden of urinary-catheter-associated infection in English NHS hospitals: a probabilistic modelling study.
    Smith DRM; Pouwels KB; Hopkins S; Naylor NR; Smieszek T; Robotham JV
    J Hosp Infect; 2019 Sep; 103(1):44-54. PubMed ID: 31047934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter to the editor regarding: the effectiveness of medicare's non-payment of hospital-acquired conditions policy.
    Kavanagh KT
    Health Policy; 2014 Dec; 118(3):422-3. PubMed ID: 25201486
    [No Abstract]   [Full Text] [Related]  

  • 14. Questionable validity of the catheter-associated urinary tract infection metric used for value-based purchasing.
    Calderon LE; Kavanagh KT; Rice MK
    Am J Infect Control; 2015 Oct; 43(10):1050-2. PubMed ID: 26139001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Not paying for catheter-associated urinary tract infections: more difficult than it seems?
    Clark RE; Clements KM
    Med Care; 2014 Jun; 52(6):479-81. PubMed ID: 24824534
    [No Abstract]   [Full Text] [Related]  

  • 16. Hospital-acquired catheter-associated urinary tract infection: documentation and coding issues may reduce financial impact of Medicare's new payment policy.
    Meddings J; Saint S; McMahon LF
    Infect Control Hosp Epidemiol; 2010 Jun; 31(6):627-33. PubMed ID: 20426577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Medicare's nonpayment for Hospital-Acquired Conditions: lessons for future policy.
    Waters TM; Daniels MJ; Bazzoli GJ; Perencevich E; Dunton N; Staggs VS; Potter C; Fareed N; Liu M; Shorr RI
    JAMA Intern Med; 2015 Mar; 175(3):347-54. PubMed ID: 25559166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs of ambulatory pediatric healthcare-associated infections: Central-line-associated bloodstream infection (CLABSIs), catheter-associated urinary tract infection (CAUTIs), and surgical site infections (SSIs).
    Rinke ML; Oyeku SO; Ford WJH; Heo M; Saiman L; DeLaMora P; Rabin B; Zachariah P; Rosenberg RE; Mirhaji P; Obaro-Best O; Drasher M; Klein E; Peshansky A; Bundy DG
    Infect Control Hosp Epidemiol; 2020 Nov; 41(11):1292-1297. PubMed ID: 32880250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Costs of infection associated with urinary bladder probes in a teaching hospital in Santander, Colombia].
    Rodríguez-Burbano L; Pio De La Hoz F; Leal-Castro AL
    Rev Salud Publica (Bogota); 2016 Feb; 18(1):104-116. PubMed ID: 28453158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the Centers for Medicare and Medicaid Services Hospital-Acquired Conditions Policy on Billing Rates for 2 Targeted Healthcare-Associated Infections.
    Kawai AT; Calderwood MS; Jin R; Soumerai SB; Vaz LE; Goldmann D; Lee GM
    Infect Control Hosp Epidemiol; 2015 Aug; 36(8):871-7. PubMed ID: 25906824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.